Innovation in biopharmaceuticals: A conversation with Fujifilm leaders

With expansive scientific expertise and united under a “Partners for Life” strategy, Fujifilm has built its Life Sciences Business Group to deliver end-to-end life science solutions and CDMO services.

In this session, you’ll gain practical insight into how innovation, scalability and a broad portfolio of expertise can best support and shorten development timetables of next-generation pharmaceuticals. Fujifilm will share a behind-the-scenes look at how Fujifilm's full range of services including CDMO capabilities, cell and media expertise, and digital and AI-driven tools help biopharma teams move faster without sacrificing quality.

What attendees will take away:

How Fujifilm has leveraged its past to become a leader in life sciences
Best practices to reduce end-to-end development timelines
Insight on how digital and AI tools can accelerate research and development

First name

Last name

Company

Job Title

Country

No cost to register, subject to confirmation

By registering for this event, you accept that you may receive direct communication from Endpoints News and/or the sponsor(s). View how we use your data here.

If you are experiencing problems with your registration, please try the Zoom registration page.

Toshihisa Iida

Director, Corporate Vice President, Chairman & General Manager, FUJIFILM Corporation

Toshihisa “Toshi” Iida has been part of Fujifilm Corporation for over three decades. Throughout his remarkable journey since joining Fuji Photo Film in 1991, Toshi has successfully held key leadership roles in Japan, Europe, and the United States. In June 2024, Toshi was appointed to the Board of Directors for FUJIFILM Corporation as Vice President, General Manager of the Life Science Strategy Headquarters and Bio CDMO Division, in addition to his role of Chairman for FUJIFILM Diosynth Biotechnologies.

Prior to his current roles, Toshi served as President and CEO of FUJIFILM Europe GmbH based in Dusseldorf, Germany, and FUJIFILM Europe B.V., with headquarters in Tilburg in the Netherlands.

Toshi received his degree from Keio University in Tokyo, Japan in 1991.

Brandon Pence

President & Chief Operating Officer, FUJIFILM Biosciences

Brandon Pence joined Fujifilm Biosciences as President and Chief Operating Officer in 2024. In his current role, he has direct oversight of teams in global manufacturing and quality, finance, R&D, human resources, and all commercial operations for the business. Brandon has a proven track record of global business growth and strategy development in life science companies including Thermo Fisher Scientific and GE Healthcare.

Prior to joining FUJIFILM Biosciences, he was Vice President of Business Development and Strategy at Avantor Sciences and has held Vice President / General Manager positions at Thermo Fisher Scientific leading a variety of businesses including Cell Biology, Purification and Pharma Analytics. Prior to that, Brandon led market development and strategy for GE Healthcare’s bioprocessing division (now known as Cytiva).

Brandon Pence is a graduate of Utah State University and started his career as a scientist working in the development of cell culture processes for mammalian and insect cells prior to moving into business-focused roles. He and wife relocated to Southern California as a part of joining Fujifilm.

moderator

Arsalan Arif

Founder & publisher, Endpoints news

Arsalan Arif is a news media entrepreneur who set out in 2015 to build his vision of an independent biotech news company at Endpoints News.